Status:

COMPLETED

AN-PEP on Gluten Exposure in Celiacs

Lead Sponsor:

Dr. C. Bonorino Udaondo Gastroenterology Hospital

Conditions:

Celiac Disease

Eligibility:

All Genders

17-75 years

Phase:

PHASE4

Brief Summary

The AN-PEP, an Aspergillus niger derived endopeptidase, has been developed aiming to produce a complete luminal detoxification of gluten. If AN-PEP is able to produce a complete luminal digestion of g...

Detailed Description

Background: The strict gluten-free diet (GFD) is the only accepted treatment for celiac disease (CeD). However, performing a strict diet is still a non solved problem affecting the future of patients....

Eligibility Criteria

Inclusion

  • Over 18 years
  • Diagnosis of celiac disease
  • Completion of Gluten-free Diet for at least two years without evidence of voluntary violations.
  • Patients who do not report symptoms of constipation or illnesses or medications (cathartics, antidiarrheals, etc.) that alter the bowel movement rhythm (accepted rhythm: between 2 times / day to 1 every other day) and diuresis (diuretics). Proton-pump inhibitor.
  • Signature of the informed consent

Exclusion

  • Patients not interested or unable to collaborate with the questionnaires and collection of fecal matter.
  • Place of residence of the participant more than 4 hours from the hospital, which interferes with the viability of the sample.
  • Complicated CD (refractory CD type II, ulcerative jejunoileitis, lymphoma).
  • Concomitant pathologies that are decompensated or untreated at study entry (type I or II diabetes mellitus; hyperthyroidism; hypothyroidism; kidney failure,).

Key Trial Info

Start Date :

March 17 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2022

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04788797

Start Date

March 17 2021

End Date

July 31 2022

Last Update

February 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr. C. Bonorino Udaondo Gastroenterology Hospital

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, 1602